Review: Diagnosis and management of primary aldosteronism

Conn JW The evolution of primary aldosteronism: 1954-1967. Harvey Lect 1968;62:257-91.

Hiramatsu K. , Yamada T. , Yukimura Y., Komiya I. , Ichikawa K. , Ishihara M. , et al. A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity . Arch Intern Med 1981;141:1589-93.

Gordon RD , Stowasser M. , TunnyTJ, Klemm SA , Rutherford JC High incidence of primary aldosteronism in 199 patients referred with hypertension . Clin Exp Pharmacol Physiol 1994; 21:315-18.

Gordon RD , Ziezak MD , TunnyTJ, Stowasser M. , Klemm SA Evidence that primary aldosteronism may not be uncommon- twelve percent incidence among antihypertensive drug trial volunteers. Clin Exp Pharmacol Physiol 1993;20:296-8.

Gordon RD , Stowasser M. , Klemm SA , Tunny TJ Primary aldosteronism and other forms of mineralocorticoid hypertension . In: Swales JD (ed.), Textbook of Hypertension. London: Blackwell Scientific; 1994, pp. 865-92.

Gordon RD Mineralocorticoid hypertension. Lancet 1994 ;344:240-43.

Young WF Jr. Primary aldosteronism: a common and curable form of hypertension. Cardiol Rev 1999;7:207-14.

Lim PO , Dow E. , Brennan G. , Jung RT , MacDonald TM High prevalence of primary aldosteronism in the Tayside hypertension clinic population. J Hum Hypertens 2000;14:311-15.

Loh K-C. , Koay ES , Khaw M-C. et al. Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore. J Clin Endocrinol Metab 2000;85:2854-9.

Rayner BL , Opie LH , Davidson JS The aldosterone/renin ratio as a screening test for primary aldosteronism . S Afr Med J 2000;90:394-400.

Fardella CE , Mosso L. , Gomez-Sanchez C. et al. Primary aldosteronism in essential hypertensives: prevalence, biochemical profile and molecular biology. J Clin Endocrinol Metab 2000;85:1863-7.

Kaplan NM Clinical Hypertension. 6th edition. Baltimore: Williams and Wilkins; 1994; pp. 389-408.

Ganguly A. Primary aldosteronism. N Engl J Med 1998; 339:1828-34.

Conn JW Plasma renin activity in primary aldosteronism. Importance in differential diagnosis and in research of essential hypertension. J Am Med Assoc 1964;190:222-5.

Kaplan NM Commentary on the incidence of primary aldosteronism. Current estimations based on objective data. Arch Intern Med 1969 ;123:152-5.

Laragh JH , Sealey JE , Sommers SC Patterns of adrenal secretion and urinary excretion of aldosterone and plasma renin activity in normal and hypertensive subjects. Circ Res 1966;18:158-74.

Fishman LM , Küchel O. , Liddle GW , Michelakis AM , Gordon RD , Chick WT : Incidence of primary aldosteronism uncomplicated "essential" hypertension . JAMA 1968;205:497-502.

Lund JO , Nielsen D. , Giese J. Prevalence of primary aldosteronism. Act Med Scand 1981;646 (Suppl):54-7.

Berglund G. , Andersson O. , Wilhelmsen L. Prevalence of primary and secondary hypertension: studies in a random population. Brit Med J 1976;2:554-6.

Beevers DG , Nelson CS , Padfield PL , Barlow DH , Duncan S. , Greaves DA et al. The prevalence of hypertension in an unselected population, and the frequency of abnormalities of potassium, angiotensin II and aldosterone in hypertensive subjects. Acta Clin Belg 1974 ;29:276-80.

Anderson GS , Toftdahl DB , Lund JO , Strandgaard S. , Nielsen PE :The incidence rate of phaeochromocytoma and Conns syndrome in Denmark, 1977-1981. J Hum Hypertens 1988;2:187-9.

Gordon RD , Stowasser M. , Tunny TJ , Klemm SA , Finn WL , Krek AL Clinical and pathological diversity of primary aldosteronism including a new familial variety. Clin Exp Pharmacol Physiol 1991;18:283-6.

McKenna TJ , Sequeira SJ , Heffernan A. , Chambers J. , Cunningham S. Diagnosis under random conditions of all disorders of the renin-angiotensin-aldosterone axis, including primary aldosteronism. J Clin Endocrinol Metab 1991;73:952-7.

Crane MG , Harris JJ Effect of aging on renin activity and aldosterone excretion. J Lab Clin Med 1976;87:947-59.

Bülhler FR , Laragh JH , Baer L. , Vaughan ED , Brunner HR Propanolol inhibition of renin secretion. A specific approach to diagnosis and treatment of renin-dependent hypertensive diseases. N Engl J Med 1972;287:1209-14.

Gordon MS , Williams GH , Hollenberg NK Renal and adrenal responsiveness to angiotensin II: influence of beta adrenergic blockade. Endocrin Res 1992;18:115-31.

Oparil S. Review of therapeutic modalities acting directly via central pathways . Clin Exp Hypertens 1982;4:579-93.

Gordon RD Primary aldosteronism. J Endocrinol Invest 1995;18:495-511.

Gordon RD Diagnostic investigations in primary aldosteronism. In: Zanchetti A (ed.), Clinical Medicine Series on Hypertension. Maidenhead: McGraw-Hill International (UK) Ltd; 2001, pp. 101-14.

Fiad TM , Conway JD , Cunningham SK , McKenna TJ The role of plasma renin activity in evaluating the adequacy of mineralocorticoid replacement in primary adrenal insufficiency. Clin Endocrinol (Oxf). 1996;45:529-34.

Mitnick PD , GreenbergA, DeOreo PB , Weiner BM , Coffman TM , Walker BR , Agus ZS , Goldfarb S. Effects of two nonsteroidal anti-inflammatory drugs, indomethacin and oxaprozin, on the kidney . Clin Pharmacol Ther 1980;28:680-9.

Gordon RD , Klemm SA , Tunny TJ , Stowasser M. Gordon's syndrome: a sodium-volume dependent form of hypertension with a genetic basis. In: Laragh JH , Brenner B (ed.), Hypertension: Pathophysiology, Diagnosis and Management. New York: Raven Press, 1995;2111-23.

Wilson FH , Disse-Nicodeme S. , Choate KA , Ishikawa K. , Nelson-Williams C. , Desitter I. et al. Human hypertension caused by mutations in WNK kinases. Science 2001;293:1107-12.

Shimkets RA , Warnock DG , Bositis CM , Nelson-Williams C. , Hansson JH , Schambelan M. et al. Liddle's syndrome: heritable human hypertension caused by mutations in the β subunit of the epithelial sodium channel. Cell 1994 ;79:407-14.

White PC , Speiser PW Steroid 11β-hydroxylase deficiency and related disorders. Endocrinol Metab Clin North Am 1994; 23:325-39.

Kater CE , Biglieri EG Disorders of steroid 17 -hydroxylase deficiency. Endocrinol Metab Clin North Am 1994; 23:341-57.

Stewart PM 11β-hydroxysteroid dehydrogenase: implications for clinical medicine . Clin Endocrinol (Oxf) 1996; 44:439-99.

Arai K. , Chrousos GP Syndromes of glucocorticoid and mineralocorticoid resistance. Steroids 1995;60:173-9.

Geller DS , Farhi A. , Pinkerton N. , Fradley M. , Moritz M. , Spitzer A. , Meinke G. , Tsai FTF , Sigler PB , Lifton RP Activating mineralocorticoid reseptor mutation in hypertension exacerbated by pregnancy. Science 2000;289:119-23.

Irony I. , Biglieri EG , Perloff D. , Rubinoff H. Pathophysiology of deoxycorticosterone-secreting adrenal tumors. J Clin Endocrinol Metab 1987;65:836-40.

Walker BR , Campbell JC , Fraser R. , Stewart PM , Edwards CRW. Mineralocorticoid excess and inhibition of 11β-hydroxysteroid dehydrogenase in patients with ectopic ACTH. Clin Endocrinol 1992;37:483-92.

Brunner HR , Laragh JH , Baer L. et al. Essential hypertension: renin and aldosterone, heart attack and stroke. N Engl J Med 1972;286:441-9.

Stowasser M. Primary aldosteronism: rare bird or common cause of secondary hypertension? Curr Hypertens Reports 2001;3:230-39.

Lim PO , Jung RT , MacDonald TM Raised aldosterone to renin ratio predicts antihypertensive efficacy of spironolactone: a prospective cohort follow-up study. Br J Clin Pharmacol 1999;48:756-60.

Lifton RP , Dluhy RG , Powers M. et al. A chimaeric 11βhydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature 1992;355:262-5.

Jonsson JR , Klemm SA , TunnyTJ, Stowasser M. , Gordon RD A new genetic test for Familial Hyperaldosteronism Type I aids in the detection of curable hypertension. Biochem Biophys Res Comm 1995;207:565-71.

Gordon RD , Stowasser M. Familial forms broaden horizons in primary aldosteronism. Trends Endocrinol Metab 1998; 9:220-7.

Stowasser M. , Gordon RD , Tunny TJ , Klemm SA , Finn WL , Krek AL Primary aldosteronism - implications of a new familial variety. J Hypertens 1991;9(suppl 6):S264-S265.

Weber KT , Brilla CG Pathological hypertrophy and cardiac interstitium: fibrosis and renin-angiotensin-aldosterone system. Circulation 1991;83:1849-65.

Rossi GP , Sacchetto A. , Pavan E. et al. Remodeling of the left ventricle in primary aldosteronism due to Conn's adenoma. Circulation 1997;95:1471-8.

Pitt B. , Zannad F. , Remme WJ et al.The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 1999 ;341:709-17.

Manhem P. , Hokfelt B. Prolonged clonidine treatment: catecholamines, renin activity and aldosterone following exercise in hypertensives. Acta Med Scand 1981;209:253-60.

Cappuccio FP , Markandu ND , Sagnella GA , Singer DR , Buckley MG , Miller MA , MacGregor GA Effects of amlodipine on urinary sodium excretion, renin-angiotensin-aldosterone system, atrial natriuretic peptide and blood pressure in essential hypertension. J Hum Hypertens 1991;5:115-19.

Gordon RD , Wolfe LK , Island DP , Liddle GW A diurnal rhythm in plasma renin activity in man. J Clin Invest 1966; 43:1587-92.

Michelakis AM , Horton R. The relationship between plasma renin and aldosterone in normal man. Circ Res 1970;26 and 27(Suppl I):I-185-I-202.

FiadTM, Cunningham SK , Hayes FJ , McKenna TJ Effects of nifedipine treatment on the renin-angiotensin-aldosterone axis. J Clin Endocrinol Metab 1997;82:457-60.

Brown MJ , Hopper RV Calcium-channel blockade can mask the diagnosis of Conn's syndrome . Postgrad Med J 1999; 75:235-6.

Stowasser M. , Gordon RD , Klemm SA , Tunny TJ Renin-aldosterone response to dexamethasone in glucocorticoid-suppressible hyperaldosteronism is altered by coexistent renal artery stenosis. J Clin Endocrinol Metab 1993;77:800-04.

Gordon RD , TunnyTJ Aldosterone-producing adenoma (A-P-A): effect of pregnancy. Clin Exp Hypertens Theory Pract 1982;A4:1685-93.

Murphy BF , Whitworth JA , Kincaid-Smith P. Malignant hypertension due to an aldosterone producing adrenal adenoma . Clin Exp Hypertens Theory Pract 1985; A7:939-50.

Young WF Jr. Primary aldosteronism: update on diagnosis and treatment . The Endocrinologist 1997;7:213-21.

Nakamura T. , Ichikawa S. , Sakamaki T. , Sato K. , Kogure M. , Tajima Y. , Kato T. , Murata K. Role of atrial natriuretic peptide in mineralocorticoid escape phenomenon in patients with primary aldosteronism. Proc Soc Exp Biol Med 1987;185:448-54.

Lyons DF , Kem DC , Brown RD et al. Single dose captopril as a diagnostic test for primary aldosteronism . J Clin Endocrinol Metab 1983;57:892-6.

Sica DA , Hollenberg NK The renal profile of eprosartan. Pharmacotherapy 1999;19:86S-94S.

Guthrie GP Jr. , McAllister RG Jr. , Kotchen TA Effects of intravenous and oral verapamil upon pressor and adrenal steroidogenic responses in normal man. J Clin Endocrinol Metab 1983;57:339-43.

Leenen FH , Smith DL , Farkas RM , Reeves RA , Marquez-Julio A. Vasodilators and regression of left ventricular hypertrophy. Hydralazine versus prazosin in hypertensive humans. Am J Med 1987;82:969-78.

Gordon RD , Gomez-Sanchez CE , Hamlet SM , Tunny TJ , Klemm SA Angiotensin-responsive aldosterone-producing adenoma masquerades as idiopathic hyperaldosteronism (IHA: adrenal hyperplasia) or low-renin essential hypertension . J Hypertens 1987;5[Suppl 5]:S103-S106.

Padfield PL , Allison MEM , Brown JJ , Ferriss JB , Fraser R. , Lever AF , Luke RG , Robertson JIS. Response of plasma aldosterone to fludrocortisone in primary aldosteronism and other forms of hypertension. Clin Endocrinol 1975 ;4:493-500.

Lund JO , Nielsen MD Fludrocortisone suppression test in normal subjects, in patients with essential hypertension and in patients with various forms of aldosteronism . Acta Endocrinol 1980;93:100-07.

Vaughan NJA , Jowett TP , Slater JDH , Wiggins RC , Lightman SL , Ma JTC , Payne NN The diagnosis of primary aldosteronism. Lancet 1981;1:120-25.

Litchfield WR , Dluhy RG Primary aldosteronism. Endocrinol . Metab Clin North Am 1995;24:593-612.

Holland OB , Brown H. , Kuhnert LV , Fairchild C. , Risk M. , Gomez-Sanchez CE Further evaluation of saline infusion for the diagnosis of primary aldosteronism . Hypertension 1984; 6:717-23.

Kem DC , Weinberger MH , Mayes DM , Nugent CA Saline suppression of plasma aldosterone in hypertension. Arch Intern Med 1971;128:380-6

Soma R. , Miyamori , Nakagawa A. et al. Possible association of aldosterone producing adenoma and non-functioning adrenal tumour . J Endocrinol Invest 1989;12:183-6.

McAlister FA , Lewanczuk RZ Primary hyperaldosteronism and adrenal incidentaloma: an argument for physiological testing before adrenalectomy . Can J Surg 1998;41:299-305.

Sutherland DJA , Ruse JL , Laidlaw JC Hypertension, increased aldosterone secretion and low plasma renin activity relieved by dexamethasone . Can Med Assoc J 1966;95:1109-19.

Giebink GS , Gotlin RW , Biglieri EG , Katz FH A kindred with familial glucocorticoid-suppressible aldosteronism. J Clin Endocrinol Metab 1973;36:715-23.

Stowasser M. , Gartside MG , Gordon RD A PCR-based method of screening individuals of all ages, from neonates to the elderly, for Familial Hyperaldosteronism Type I. Aust NZ J Med 1997 ;27:685-90.

Stowasser M. , Gordon RD Primary aldosteronism: learning from the study of familial varieties. J Hypertens 2000;18:1165-76.

Stowasser M. , Tunny TJ, Gartside M. , Taylor WL , Gordon RD In Familial Hyperaldosteronism Type I, hybrid gene-induced aldosterone production dominates that induced by wild type genes . J Clin Endocrinol Metab 1997;82:3670-76.

Connell JMC , Kenyon CJ , Corrie JET , Fraser R. , Watt R. , Lever AF Dexamethasone-suppressible hyperaldosteronism: adrenal transitional cell hyperplasia? Hypertension 1986;8:669-76.

Gill JR , Bartter FC Overproduction of sodium-retaining steroids by the zona glomerulosa is adrenocorticotropindependent and mediates hypertension in dexamethasone-suppressible aldosteronism. J Clin Endocrinol Metab 1981 ; 53:331-7.

Stowasser M. , Bachmann AW , Huggard PJ , Rossetti TR , Gordon RD Treatment of familial hyperaldosteronism type I: only partial suppression of hybrid gene required to correct hypertension . J Clin Endocrinol Metab 2000;85:3313-18.

Stowasser M. , Bachmann AW , Jonsson JR , Tunny TJ , Klemm SA , Gordon RD Clinical, biochemical and genetic approaches to the detection of Familial Hyperaldosteronism Type I. J Hypertens 1995;13:1610-13.

Mulatero P. , Veglio F. , Pilon C. et al. Diagnosis of glucocorticoid-remediable aldosteronism in primary aldosteronism: aldosterone response to dexamethasone and long polymerase chain reaction for chimeric gene. J Clin Endocrinol Metab 1998;83:2573-75.

Litchfield WR , New MI , Coolidge C. , Lifton RP , Dluhy RG Evaluation of the dexamethasone suppression test for the diagnosis of glucocorticoid-remediable aldosteronism. J Clin Endocrinol Metab 1997 ;82:3570-3.

Stowasser M. , Bachmann AW , Huggard PJ , Rossetti TR , Gordon RD Severity of hypertension in familial hyperaldosteronism type I: relationship to gender and to degree of biochemical disturbance. J Clin Endocrinol Metab 2000;85:2160-66.

Kem DC , Weinberger MH , Higgins JR , Kramer NJ , Gomez-Sanchez C. , Holland OB Plasma aldosterone response to ACTH in primary aldosteronism and in patients with low renin hypertension. J Clin Endocrinol Metab 1978;46:552-60.

Doppman JL , Gill JR Hyperaldosteronism: sampling the adrenal veins. Radiology 1996;198:309-12.

Stowasser M. , Gordon RD Prevalence and diagnostic workup of primary aldosteronism. Nephrology 2001;6:119-26. 91. Woods JJ , Sampson ML , Ruddel ME , Remaley AT Rapid intraoperative cortisol assay: design and utility for localizing adrenal tumors by venous sampling. Clin Biochem 2000 ; 33:501-03.

Neville AM , O'Hare MJ Histopathology of the human adrenal cortex. Clin Endocrinol Metab 1985;14:791-820.

Ganguly AG , Melada GA , Luetscher JA , Dowdy AJ Control of plasma aldosterone in primary aldosteronism: distinction between adenoma and hyperplasia. J Clin Endocrinol Metab 1973;37:765-75.

Ganguly A. , Grim CE , Weinberger MH Anomalous postural aldosterone response in glucocorticoid-suppressible hyperaldosteronism . N Engl J Med 1981;305:991-3.

Ulick S. , Chu MD Hypersecretion of a new corticosteroid, 18-hydroxycortisol in two types of adrenocortical hypertension. Clin Exp Hypertens 1982; A4:1771-7.

Ulick S. , Chu MD , Land M. Biosynthesis of 18-oxocortisol by aldosterone-producing adrenal tissue . J Biol Chem 1983; 258:5498-5502.

Gomez-Sanchez CE , Montgomery M. , Ganguly A. , Holland OB , Gomez-Sanchez EP , Grim CE , Weinberger MH Elevated urinary excretion of 18-oxocortisol in glucocorticoid-suppressible aldosteronism. J Clin Endocrinol Metab 1984;59:1022-24.

Gordon RD , Hamlet SM , Tunny TJ , Gomez-Sanchez CE , Jayasinghe LS Distinguishing aldosterone-producing adenoma from other forms of hyperaldosteronism and lateralizing the tumour pre-operatively. Clin Exp Pharmacol Physiol 1986; 13:325-8.

Torpy DJ , Gordon RD , Stratakis CA Linkage analysis of familial hyperaldosteronism type II - absence of linkage of the gene encoding the angiotensin II receptor type 1. J Clin Endocrinol Metab 1998;83:1046.

Torpy DJ , Gordon RD , Lin J-P. et al. Familial hyperaldosteronism type-II: description of a large kindred and exclusion of the aldosterone synthase (CYP11B2) gene. J Clin Endocrinol Metab 1998; 83:3214-18.

LaffertyAR , Torpy DJ , Stowasser M. et al.A novel locus for low-renin hypertension: familial hyperaldosteronism type II maps to chromosome 7 (7p22) . JMed Genet 2000;37:831-5. 102. Gordon RD Mineralocorticoid excess syndromes. In: Margioris AN, Chrousos GP (eds.), Contemporary Endocrinology: Adrenal Disorders. Humana Press, New Jersey. 2000;355-77.

Stowasser M. , Klemm SA , Tunny TJ , Storie WJ , Rutherford JC , Gordon RD Response to unilateral adrenalectomy for aldosterone-producing adenoma - effect of angiotensin responsiveness and potassium levels. Clin Exp Pharmacol Physiol 1994; 21:319-22.

Rutherford JC , Taylor WL , Stowasser M. , Gordon R. Success of surgery in primary aldosteronism judged by residual autonomous aldosterone production . World J Surg 1998; 22:1243-5.

Rutherford JC , Stowasser M. , Tunny TJ , Klemm SA , Gordon RD Laparoscopic adrenalectomy . World J Surg 1996;20:758-60.

Gagner M. , Pomp A. , Heniford BT , Pharand D. , Lacroix A. Laparoscopic adrenalectomy. Lessons learned from 100 consecutive procedures .Ann Surg 1997;26:238-47.

Gordon RD , Rutherford JC , Stowasser M. Primary aldosteronism: are we diagnosing and operating on too few patients? World J Surg 2001;25:941-7.

Kaplan NM Cautions over the current epidemic of primary aldosteronism. Lancet 2001;357:953-4. 109. Delyani JA Mineralocorticoid receptor antagonists: the evolution of utility and pharmacology. Kidney Int 2000; 57:1408-11.

Walker BR , Edwards CRW. Dexamethasone-suppressible hypertension.Endocrinologist 1993;3:87-97. 111. White PC Inherited forms of mineralocorticoid hypertension .Hypertension 1996;28:927-36.